Abiopharma

News list

Director Paul Elaine 🟡 adjusted position in 0 shares (1 derivative) of Marqeta, Inc. (MQ) Transaction Date: Apr 18, 2026 | Filing ID: 000002

Full text

News bot April 21, 2026, 8:31 p.m.
🔍 Paul Elaine (Director)

Company: Marqeta, Inc. (MQ)

Report Date: 2026-04-18
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 34,905
- Total shares sold: 34,905
Detailed Transactions and Holdings:
- Acquired 34,905 shares of Class A Common Stock (Direct)
  Date: 2026-04-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 34,905.00 | transaction_form_type: 4 | Footnotes: F1, F1
- Sold 34,905 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 69,807.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
Footnotes:
- F1: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.
- F2: Each restricted stock unit is convertible into one share of Class A Common Stock.
- F3: One-third (1/3rd) of the restricted stock units vest on each of April 18, 2026, April 18, 2027 and April 18, 2028, subject to the Reporting Person's continued service with the Issuer as of each vesting date.